XML 71 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Statements of Cash Flows (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Operating activities:    
Net loss $ (26,663,829) $ (7,219,236)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on extinguishment of debt and other liabilities   (2,420,000)
Depreciation expense 33,285 26
Amortization of debt issuance costs   4,000
Amortization of premium/discount on investments 124,000 752,000
Stock-based compensation expense 5,123,564 438,052
Changes in operating assets and liabilities:    
Accounts receivable 78,000 (80,000)
Prepaid expenses and other current assets (688,000) (28,000)
Accounts payable and accrued expenses 3,683,000 2,129,000
Other liabilities 29,000  
Net cash used in operating activities (18,280,000) (6,424,000)
Investing activities:    
Purchase of equipment (208,000) (6,000)
Proceeds from maturities of available for sale securities 6,990,000  
Purchases of available for sale securities (64,497,000) (13,154,000)
Net cash used in investing activities (57,715,000) (13,160,000)
Financing activities:    
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs   42,546,000
Repurchase of treasury stock (79,000)  
Proceeds from issuance of common stock, net of issuance costs 104,293,000  
Proceeds from receipt of payment on promissory notes issued in exchange for shares of common stock 237,000  
Payments on capital lease obligations (3,000)  
Net cash provided by financing activities 104,448,000 42,546,000
Increase in cash and cash equivalents 28,453,000 22,962,000
Cash and cash equivalents at beginning of period 21,215,228 1,641,000
Cash and cash equivalents at end of period 49,667,984 24,603,000
Non-cash financing activities:    
Accretion of preferred stock to redemption value 86,899,000 52,862,000
Unpaid initial public offering issuance costs 15,000,000 0
Reclassification of 2012 Series X preferred stock from debt to preferred stock   2,486,000
Conversion of 2012 Series X preferred stock into Series C preferred stock   $ 4,944,000